Senior Principal Scientist
Bristol-Myers Squibb Company
Nanda Balasubramanian, PhD
Senior Principal Scientist, Non-Dispositional Bioanalysis,
Bristol Myers Squibb
Nanda brings 10+ years of experience in molecular assays, immunoassay and bioanalytical experience. As a bioanalytical lead he has supported biologics, mRNA therapeutics, ASO, Gene Therapy and CAR-T. In his current role as Senior Principal Scientist at BMS he supports bioanalysis for CAR-T, gene therapy and large molecules. Prior to BMS he has held the bioanalytical lead scientist roles in increasing responsibilities at Alexion, Pfizer and Astra Zeneca. He has been part of various industry working groups including AAPS and IQ consortium. He has also co-authored reviews regarding bioanalytical strategies and approaches, specifically for new modalties. He did his postdoc at Yale University School of Medicine applying DNA repair, high-throughput screening, anti-sense oligos, nanoparticles, and gene therapy.